This topic contains a solution. Click here to go to the answer

Author Question: A depressed, suicidal client is scheduled for electroconvulsive therapy (ECT), which requires ... (Read 55 times)

ARLKQ

  • Hero Member
  • *****
  • Posts: 571
A depressed, suicidal client is scheduled for electroconvulsive therapy (ECT), which requires consent. Legally, who should sign the consent for this treatment?
 
  A) A member of the treatment team
  B) The client
  C) The client's spouse
  D) The psychiatrist

Question 2

A client with major depression visits the mental health clinic and tells the nurse that he has recently started smoking marijuana. The nurse determines that the manifestation of the client's co-occurring disorder is:
 
  A) Primary mental illness with subsequent substance abuse.
  B) Primary substance abuse disorder with psychopathologic sequelae.
  C) Dual primary diagnoses.
  D) A common etiology.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

janeli

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

B
Feedback: The client has the right to sign (or refuse to sign) the consent; the others do not have the legal right to sign for the client.

Answer to Question 2

A




ARLKQ

  • Member
  • Posts: 571
Reply 2 on: Jul 19, 2018
YES! Correct, THANKS for helping me on my review


steff9894

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The highest suicide rate in the United States is among people ages 65 years and older. Almost 15% of people in this age group commit suicide every year.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

For a complete list of videos, visit our video library